Published in J Urol on September 18, 2010
Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study. PLoS One (2012) 0.90
Brain-derived neurotrophic factor promotes nerve regeneration by activating the JAK/STAT pathway in Schwann cells. Transl Androl Urol (2016) 0.77
Stones: Morning spot urine samples are better than 24 h urine for assessment of lithogenic risk in children. Nat Rev Urol (2011) 0.75
Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res (2005) 1.26
Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol (2013) 1.25
KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11
Patients' perceptions of GP non-verbal communication: a qualitative study. Br J Gen Pract (2010) 1.07
Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci (2003) 1.02
HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma. J Pharm Biomed Anal (2006) 0.98
Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls? J Urol (2006) 0.94
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kidney Dis (2005) 0.91
Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90
Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. Br J Nutr (2003) 0.90
Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89
Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation. Pediatr Nephrol (2005) 0.88
The patient's view of the acceptability of the primary care in Poland. Int J Qual Health Care (2008) 0.88
Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? Pediatr Nephrol (2014) 0.86
Oxalate and its handling in a low stone risk vs a stone-prone population group. World J Urol (2005) 0.85
Involvement of family nurses in home visits during an 8-year period encompassing primary healthcare reforms in Poland. Health Soc Care Community (2008) 0.85
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81
Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81
Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81
Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81
Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol (2006) 0.81
Little evidence of low bone mass in acute lymphoblastic leukemia survivors. J Clin Densitom (2011) 0.80
Urolithiasis--an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int (2015) 0.80
Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis. Pediatr Nephrol (2013) 0.80
Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80
A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80
Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI. Clin Chem Lab Med (2009) 0.80
Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer. Urol Res (2009) 0.79
Influence of a variable differential function on the stone-growth-related urinary depletion effect. Clin Chem (2004) 0.79
Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79
Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis. Mediators Inflamm (2013) 0.79
[Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Pol Merkur Lekarski (2007) 0.79
Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79
Metabolic stress response patterns in urinary compositions of idiopathic calcium oxalate stone formers, patients with chronic bowel diseases and controls. Urol Res (2010) 0.78
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78
Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78
A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78
Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78
Comparison of phalangeal ultrasound and dual energy X-ray absorptiometry in healthy male and female adolescents. Ultrasound Med Biol (2005) 0.78
Body composition and bone mass in survivors of childhood cancer. Pediatr Blood Cancer (2007) 0.78
[Bone mineral density in children before and after completion of cancer treatment]. Pol Merkur Lekarski (2004) 0.77
Hyperoxaluria, hypocitraturia, hypomagnesiuria, and lack of intestinal colonization by Oxalobacter formigenes in a cervical spinal cord injury patient with suprapubic cystostomy, short bowel, and nephrolithiasis. ScientificWorldJournal (2006) 0.77
[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77
[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77
[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76
Does Q223R Polymorphism of Leptin Receptor Influence on Anthropometric Parameters and Bone Density in Childhood Cancer Survivors? Int J Endocrinol (2013) 0.76
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76
Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease? Pediatr Hematol Oncol (2009) 0.76
Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75
High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome. Pediatr Nephrol (2006) 0.75
Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75
New insight into the role of patients during medical appointments: a synthesis of three qualitative studies. Patient (2014) 0.75
Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol (2014) 0.75
Serum matrix metalloproteinase-9 levels and severity of symptoms in boys with attention deficit hyperactivity disorder ADHD/hyperkinetic disorder HKD. Eur Child Adolesc Psychiatry (2014) 0.75
Asymmetric and symmetric dimethylarginine in adolescents with hyperuricemia. Dis Markers (2013) 0.75
Low milk consumption in childhood and fragility fractures. Comment on an article by Monti et al. Ann Nutr Metab (2008) 0.75
Some remarks on self-reported and measured height and weight in adolescents. J Adolesc Health (2006) 0.75
[Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski (2003) 0.75
[Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski (2005) 0.75
[Vasculitis of cerebral vessels, probable cause of neurological complications in a child with Schonlein-Henoch purpura]. Pol Merkur Lekarski (2002) 0.75
[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75
[Bone mineral density in children and adolescents with idiopathic chronic musculoskeletal pain syndromes]. Pol Merkur Lekarski (2006) 0.75
[Contemporary vaccinology--scientific and practical aspects]. Pol Merkur Lekarski (2002) 0.75
[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75
High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75
Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr (2006) 0.75
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
Vitamin D status in Poland. Pol Arch Med Wewn (2016) 0.75
[Prevention of infections in primary and secondary antibody deficiency]. Przegl Epidemiol (2009) 0.75
[Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski (2004) 0.75
The case: A boy with recurrent stones. Kidney Int (2008) 0.75
[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski (2006) 0.75
[Vertebral compression fractures--the first manifestations of acute lymphoblastic leukemia of childhood]. Med Wieku Rozwoj (2005) 0.75
Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr (2006) 0.75
Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75
[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75
[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75
Coenzyme Q10 level in plasma of children with inflammatory process. Rocz Akad Med Bialymst (2002) 0.75
[Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis]. Pol Merkur Lekarski (2008) 0.75
[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75
[The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski (2005) 0.75